emulsion for oral delivery of allyl isothiocyanate [10] . Hydrogel microspheres of chitosan crosslinked with glutaraldehyde with uniform-size have been produced by a membrane emulsification technique [11] , and a water-in-oil (W/O) emulsion coalescence technique was proposed for the production of CHI particles using vegetable oil [12] . Both methods generated microspheres with enhanced control of particle size and particle size distribution, which are important for repeatable controlled release behavior [11, 12] . Despite some different water-inoil methods have been used to produce microspheres [13] [14] [15] [16] , they have not been utilized for the preparation of ALG-CHI microspheres to enhance the encapsulation of water-soluble drugs. Ionic and covalent crosslinkers can be added to the ALG-CHI system for improving the properties. Calcium chloride is frequently used as an ionic crosslinker in ALG-CHI systems [7] [8] [9] 11 ] causing a reduction in the hydrogel porosity [17] . Among the covalent crosslinkers, there are some reports for chitosan nanoparticles crosslinked with glutaraldeyde [13, 18] and genipin [19, 20] . Genipin is a natural covalent crosslinker that presents very low toxicity in comparison with conventional crosslinkers and can present promising results in the reinforcement of ALG-CHI based microspheres [20] . In this work, a novel W/O emulsion method was designed for ALG-CHI microspheres' preparation using two types of crosslinker, calcium ions and genipin, and two types of surfactant agents with a view to increase the drug loading of some model drugs. The properties of the ALG-CHI particles produced in emulsion by different methods were compared with those obtained by the aqueous method.
Experimental 2.1. Materials
Alginic acid sodium salt (~250 mPa·s viscosity at 25°C 1 wt%, 64.4 kDa) and polyvinyl pirrolidone (40 kDa) was purchased from Sigma. Low molecular weight Chitosan (90% deacetylated, 6.68 kDa) was purchased from Aldrich. Calcium chloride and polyvinyl alcohol (86.5-89.5% hydrolyzed, 30-70 kDa) were purchased from Synth. Genipin was purchased from Challenge Bioproducts. Fluorescein salt was supplied by Synth, lisinopril and fluorescein isothiocianate were supplied by Sigma. All reagents were analytical grades and were used as received.
Microspheres preparation
ALG-CHI microspheres were produced in W/O emulsion, testing two types of surfactant and two types of crosslinker, resulting in four different formulations in emulsion. Also ALG-CHI microspheres were produced in aqueous medium, as described in earlier work [8] , for comparison of properties. Polymer complexes were prepared using appropriate proportions, in order to obtain hydrogels with polymer ratio ALG:CHI = 35:65, condition previously optimized in previous articles [8, 9] . The model drugs were added using a mass ratio Polymer:Drug of 5:1, condition optimized prior the design. Six formulations were produced in triplicate, the conditions are shown in Table 1 . Aqueous solution of ALG (1% w/v) were prepared and diluted to a final concentration of 0.2% w/v using distilled water. CHI solution (1% w/v) were dissolved in an acetic acid solution with pH = 3, and further diluted to (0.2% w/v) with distilled water. ALG-CHI-Ca +2 microspheres were prepared by placing the solution of CHI 0.2% and ALG 0.2% in separate tubes and adding the 2 mM CaCl 2 solution into the tube with CHI solution and homogenized. The surfactant powder was added in each tube in a 1.5% w/v concentration and homogenized in an ultrasonic bath for 25 min. Both tubes were carefully added to a vessel containing mineral oil in a volume ratio 6:1 mineral oil: aqueous phase. The mixture was vigorously sonicated with an ultrasonic probe for 3 min producing a stable emulsion, and then replaced in the ultrasonic bath for additional 20 min. The emulsion was centrifuged at 3500 rpm for 30 min for aqueous and oil-phase 457 Abreu et al. -eXPRESS Polymer Letters Vol.4, No.8 (2010) Figure 1 shows a schematic representation of the components in all steps of the ALG-CHI nanoparticles preparation by the water-in-oil method.
Microspheres characterization
Hydrogel samples were dried and then sputtercoated with gold for Scanning Electron Microscope (SEM) characterization in a Jeol JSM 5800 microscope, using an acceleration voltage of 5 kV. The morphology was investigated through Fluorescence Optical microscope (OM) (Leitz Wetzlar). The loading and the encapsulation efficiency were determined by UV/VIS spectroscopy, at 489 and 499 nm, in a MICRONAL-Brazil spectrometer (model B582) as following: a 10 mg sample was crushed in ethanol and its concentration was calculated using a calibration curve obtained from samples of pure fluorescein at 489 nm and lisinopril labeled with fluorescein isothiocianate (FITC) at 499 nm at certain concentration range. All analysis was replicated twice. The encapsulation efficiency (EE) was evaluated for fluorescein as model drug and for lisinopril labeled with FITC as shown by Equation (1): (1) where M is the amount of drug in loaded sample, as determined from the calibration curve and M 0 is the initial drug amount added to the complex.
Results and discussion
ALG-CHI microspheres were prepared from 0.2 wt% polymer solution having the polymer mass ratio ALG/CHI = 35/65. These conditions were chosen due to good particle stability and properties reported previously [8, 9] , where hydrogels presented higher yield and lower swelling degree. In a previous study, it was seen that CHI based microspheres prepared at aqueous medium showed low encapsulation efficiency of hydrophilic drugs (unpublished results). This could be related to the drug highly hydrophilic character, which present stronger interaction between drug-solvent (water) than the electrostatic interactions between drugmicrospheres. In this work, microspheres with controlled morphology were produced by emulsion method and by aqueous method, using two types of crosslinker and surfactant, focusing in differences in the morphology and drug distribution pattern, aiming at encapsulation efficiency optimization.
Morphology
The morphology of the ALG-CHI microspheres was observed through SEM, as shown in Figure 2 . The ALG-CHI hydrogel particles showed spherical shape and the average particle size and particles size distribution varied according to the preparation method, in aqueous medium or W/O emulsion, and to the crosslinker type, genipin or CaCl 2 . In general, there was an increase in the regularity of the particles shape when genipin was used as crosslinker agent, as revealed by the SEM micrographs ure 2a, 2c and 2e. ALG-CHI particles produced in W/O emulsion with PVA using both crosslinker agents presented a more spherical shape and regular structure, revealed by the SEM micrographs Figure 2c and 2d. and 3b). The particle agglomeration in the aqueous method is possibly caused by the formation of inter-aggregate complexes between the ALG carboxylic chains in the hydrogel induced by Ca +2 . This is in accordance with Zhu et al. [21] results, in which the agglomeration effect was observed for carboxymethyl-chitosan aqueous solutions in presence of metallic ions. This agglomeration that occurs simply by electrostatic interactions between the ions and the polymers may lead to the formation of microparticles with irregular morphology and higher polydispersity. On the other hand, microspheres prepared through the emulsion method presented uniform size with self-avoiding particles (Figure 3c and 3d) , being potentially more adequate for drug delivery. The emulsion method, due to the ALG-CHI particles arrangement inside the droplets, may prevent the formation of inter-aggregated complex caused by electrostatic interactions. Studies regarding the preparation of microparticles by emulsion were conducted by others; Kofuji et al. [12] reported chitosan microparticles chelated by metallic produced by emulsion technique with irregular morphology and rough surface; on the other hand, Wang et al. [13] obtained chitosan microparticles with excellent size control and smooth surface by a innovative membrane emulsification technique. Table 2 shows the average particle size of ALG-CHI microspheres. The average particle size of the ALG-CHI microspheres corresponds to the average diameter measured on fifty [12] . Some data on emulsion methods report particles having broad size range, due to the use of high-speed blenders and high pressure homogenizers which involves mechanical shear force to reduce the size of the emulsion droplets and forms polydisperse particles [15] . However, the formulations produced by emulsion method with PVP as surfactant presented lower polydispersity than those produced with PVA and equivalent polydispersity to those produced by aqueous medium method. PVP perhaps exhibits better stabilizing effect, where the adsorption of the polymer in the droplets surface avoids the coagulation and consequently the agglomeration of droplets.
On the other hand, PVA presents higher molecular weight than PVP (30-70 and 40 kDa, respectively) and higher affinity to the ALG-CHI polymers. In this sense, different segments of a single PVA macromolecule may absorb simultaneously on two or more droplets, leading to an attractive force which results in droplets aggregation, with consequently higher particle size and high polidispersity.
Encapsulation efficiency
Using 2% of loading of the drug models, the encapsulation efficiency was determined using a calibration curve in a UV-visible spectrometer, as described earlier. The calibration curves for fluorescein and for lisinopril labeled with FITC are in Figure 4 . The correlation between absorbance and concentration for fluorescein and lisinopril are given respectively by the Equations (2) and (3):
The curves presented excellent linearity for low and high drug concentration, with a correlation factor R 2 >0.99. The model drug's concentrations were calculated using Equations (2) and (3) and the encapsulation efficiency values for each system produced were calculated using Equation (1), as shown in Table 2 . Comparing the encapsulation efficiency (EE) values is observed that particles produced in aqueous medium presented relatively low EE in comparison with the majority of the EE values of the microspheres obtained by W/O emulsion method, which successfully entrapped over 70% of lisinopril and fluorescein. The EE of lisinopril-FITC was higher or equivalent than fluorescein, probably due to the lower hydrophilic character which may cause lower drug leaching. Genipin was more effective as crosslinker than Ca +2 for ALG-CHI microparticles loaded with lisinopril produced by aqueous method and also by W/O emulsion with PVA. In particular, there was a notable increase of 15% in the encapsulation efficiency of lisinopril when genipin was used instead of CaCl 2 in the hydrogel preparation through the aqueous method. As previously reported [19] , controlled release rates of indomethacin from ALG-CHI particles were achieved by increasing the genipin content in the hydrogel due to a higher crosslinking density. In fact, the genipin content can be manipulated in order to control the chitosan crosslink density [20] . On the other hand, when CaCl 2 was used as crosslinking agent using the W/O emulsion method the surfactant type did not have strong influence in the efficiency of both model drugs, and the formulations presented high EE values for both drugs. An analysis of the surfactant effect in the EE shows that it with PVA it was achieved the highest values of encapsulation efficiency for both drugs and using both types of crosslinker. Despite the fact that PVA has formed particles with higher polidispersity, depending upon the application of the delivery system, it might be desirable to achieve high EE values with a decrease of the control of the size. Figure 5 shows the lisinopril-FITC encapsulation and distribution within the particles investigated by Fluorescence Optical microcopy (FOM). It is evidenced in the lisinopril-FITC-ALG-CHI microspheres micrographs that the distribution pattern varied according to the preparation method and crosslinker type. In aqueous medium, the drug dispersion was favored by replacing CaCl 2 with genipin ( Figure 5a and 5b, respectively) also corroborated by the EE values. In Figure 5c and 5d the homogeneous dispersion of the drug is shown inside the ALG-CHI microspheres produced through the W/O emulsion method. Particularly, the surfactant seems to affect the encapsulation efficiency of ALG-CHI particles crosslinked with genipin. The reported mechanism for genipin-chitosan crosslinking reaction is a nucleophilic attack of chitosan amino groups in the dihydropiran ring of genipin [20] . A high loss of hydrogen ions from protonated amino groups to the carboxylic groups favors the nucleophilicity of amino groups, which in turn may increase the CHI crosslinking density [20] . In the case of the microspheres here reported, the residual carboxylic groups (25%) in the PVA molecules may favor the chitosan deprotonation, which facilitates the amino nucleophilic attack, increases the crosslinking density and consequently the encapsu- lation efficiency (85% for the system EM/PVA/ Gen loaded with lisinopril). On the other hand, in the case of the ionic crosslinker (calcium chloride), PVP and PVA were a good surfactant for the W/O system and the average EE was around 75%. In summary, ALG-CHI microspheres produced in W/O emulsion with PVA as surfactant using both types of crosslinker presented highly spherical particles with acceptable size distribution for a variety of delivery systems. On the other hand, the emulsion system ALG-CHI-Ca +2 using PVP as crosslinker presented spherical particles with lower polidispersity, desirable for some specific applications. In addition, those particles formed self-avoided domains, avoiding aggregation. Moreover, these particles presented higher encapsulation efficiency reaching values up to 75% than those produced in aqueous medium.
Conclusions
Different methods for production of ALG-CHI microspheres were tested in order to increase the encapsulation efficiency and optimize the morphology. Regarding the crosslinker type, genipin increased significantly the EE of microspheres produced in aqueous medium. It was observed that the emulsion method in general was more efficient to encapsulate the model drugs than the aqueous method. Moreover, ALG-CHI microspheres produced in emulsion using PVA as surfactant presented highly spherical particles with acceptable size distribution, and the emulsion system ALG-CHI-Ca +2 using PVP as crosslinker presented lower particle size with higher size control, desirable for some specific applications. Those particles formed self-avoided domains, avoiding aggregation and higher encapsulation efficiency reaching values up to 75%, indicating that the emulsion method is a promising route to encapsulate hydrophilic drugs.
